Pipotiazine palmitate
As of the edition of 20 October 2026, Pipotiazine palmitate is a small molecule: marketed, first approved in 1988 (FR); acts on DRD2.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1988
- Kind
- Small molecule
- Brand name
- Piportil L4
- First approved
- 18 August 1988 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Laboratoires Delbert
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| DRD2 | Dopamine receptor D2 | P14416 |